Loomis, Sayles & Company
PTLA

Loomis, Sayles & Company’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Loomis, Sayles & Company’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-627,335
Closed -$15M – 814
2019
Q4 		$15M Buy
+627,335
New +$17.3M 0.03% 276
2016
Q1 		– Sell
-287,370
Closed -$14.8M – 1167
2015
Q4 		$14.8M Buy
+287,370
New +$13.9M 0.04% 357

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Loomis, Sayles & Company's PTLA Position: Q1 2020 in Review

Loomis, Sayles & Company sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 627,335 shares — an estimated $15M sold.

Loomis, Sayles & Company first reported a position in PTLA in Q4 2015 and held it in 2 quarters. The position peaked at $15M in Q4 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • Loomis, Sayles & Company reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Loomis, Sayles & Company sold 627,335 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $15M.
  • Loomis, Sayles & Company first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 2 quarters.
  • Loomis, Sayles & Company's Portola Pharmaceuticals, Inc. position peaked at $15M in Q4 2019.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Loomis, Sayles & Company's 13F filing for Q1 2020, filed 15 May 2020.